Press Releases
🇺🇸 FDA Page 17FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 193–204 of 212 articles
Mabwell's MAIWEIJIAN Denosumab Gets NMPA Acceptance for Expanded Cancer Bone Treatment
ThinkTrends AI Platform Deployed by Federal Health Agency for Nationwide Adverse Event Monitoring System
Fullscript Journeys Launches Digital Health Platform for 125,000 Healthcare Providers
Nexalin Technology Advances FDA Strategy for Alzheimer's Treatment Following U.S. and China Leadership Meetings
ImmunityBio (IBRX) Faces FDA Warning Letter and Class Action Lawsuit Over Ankt Drug Claims
Elion Therapeutics Launches Phase 2 Trial for Turletricin (EL219) in Invasive Mold Infections
Glaukos Receives Permanent J-Code J2789 for Epioxa™ Ophthalmic Treatment, Effective July 2026
Nkarta Receives FDA Approval for Outpatient NKX019 Dosing in Autoimmune Disease Treatment
Dogwood Therapeutics SP16 Gets FDA IND Approval for Chemotherapy-Induced Pain Treatment
PDS Biotech's PDS01ADC Shows 78% Response Rate in Metastatic Colorectal Cancer Phase 2 Trial
FDA Approves RAPIBLYK (Landiolol) for Pediatric Supraventricular Tachycardia - AOP Health US Expands Critical Care Treatment Options
Psoriasis Treatment Pipeline Explodes: 90+ Companies Race to Develop Next-Generation Therapies in 2026